<DOC>
	<DOCNO>NCT01417156</DOCNO>
	<brief_summary>Primary objective study investigate long-term tolerability safety profile BIBF 1120 top pirfenidone treatment patient Idiopathic Pulmonary Fibrosis complete prior clinical trial BIBF 1120 ( 1199.31 ) . Secondary objective assess effect efficacy criterion long term treatment BIBF 1120 top pirfenidone .</brief_summary>
	<brief_title>Safety PK Study BIBF 1120 Japanese Patients With IPF : Follow Study From 1199.31 ( NCT01136174 )</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Nintedanib</mesh_term>
	<criteria>Inclusion criterion : 1 . Written inform consent consistent Good Clinical Practice ( GCP ) sign prior entry study 2 . Completion 1199.31 study still treatment pirfenidone stable dose Exclusion criterion : 1 . Any disease may interfere test procedure judgement investigator may interfere trial participation may put patient risk participate trial . Reconsider carefully exclusion criterion trial 1199.31 . However , patient may qualify participation even though meet exclusion criterion ( 1199.31 ) , investigator benefitrisk assessment remain favorable . 2 . Any investigational therapy receive within 8 week visit 1 . 3 . For female : Pregnant woman woman breast feed child bear potential use highly effective method birth control least 4 week prior enrolment 10 week last study drug intake . For male : Sexually active male commit use condom course study ten week last study drug intake ( except partner childbearing potential ) . 4 . Known suspect active alcohol drug abuse . 5 . Patients require fulldose therapeutic anticoagulation ( e.g . vitamin K antagonist , heparin ) , except low dose heparin and/or heparin flash need maintenance indwell intravenous device . As example , prophylactic use heparin , e.g . enoxaparin 2000 International unit ( I.U . ) subcutaneously ( s.c. ) per day , allow . 6 . Patients require fulldose antiplatelet ( e.g . acetyl salicylic acid , clopidogrel ) therapy . As example , chronic lowdose acetyl salicylic acid , equal 100 mg per day , allow . 7 . Patient compliant previous trial , trial medication trial visit .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>